Company news
Anixa Biosciences, Inc. news in 2025
Anixa Biosciences, Inc.'s news releases, calls and decks from 2025, newest first.
Anixa Biosciences Announces Transfer of IND for Breast Cancer Vaccine from Cleveland Clinic
December 15, 2025
Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants
December 11, 2025
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025
December 10, 2025
Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
November 17, 2025
Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
November 12, 2025
Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025
November 10, 2025
Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
November 5, 2025
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
October 23, 2025
Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
October 20, 2025
Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
October 7, 2025
Cleveland Clinic to Present Final Results of Phase 1 Clinical Trial for Anixa Biosciences' Breast Cancer Vaccine at 2025 San Antonio Breast Cancer Symposium
September 22, 2025
Anixa Biosciences and Moffitt Cancer Center Complete Dosing of Fourth Cohort in Ovarian Cancer CAR-T Clinical Trial; Multiple Patients Surpassing Median Expected Survival
September 8, 2025
Anixa Biosciences Announces Time Change for Presentation at the H.C. Wainwright 27th Annual Global Investment Conference
September 2, 2025
Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference
August 25, 2025
Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology
August 20, 2025
Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial
August 18, 2025
Anixa Biosciences Announces Issuance of Additional U.S. Patent for CAR-T Technology
August 12, 2025
Anixa Biosciences Announces Dr. Robert Wenham will speak about Immunotherapy in surviving Ovarian Cancer at the 13th Annual Ovarcoming Cancer Conference
August 8, 2025
Anixa Biosciences Announces Commencement of US FDA Approved IND Transfer to Support Upcoming Phase 2 Breast Cancer Vaccine Trial
August 4, 2025
Anixa Biosciences Receives Notice of Allowance from Canadian Intellectual Property Office for Patent Covering Breast Cancer Vaccine Technology
July 30, 2025
Anixa Biosciences Awarded New U.S. Patent Extending Breast Cancer Vaccine IP Protection into 2040s
July 24, 2025
Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology
July 9, 2025
Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial
June 23, 2025
Anixa Biosciences to Host an Investor Webcast on June 26, 2025
June 20, 2025
Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage
June 10, 2025
Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025
June 9, 2025
Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview
June 3, 2025
Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine
June 2, 2025
Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones
May 19, 2025
Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting
May 12, 2025
Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th
April 30, 2025
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio
April 14, 2025
Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology
April 9, 2025
Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th
April 1, 2025
Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines
March 25, 2025
Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine
March 24, 2025
Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th
March 17, 2025
Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
March 10, 2025
Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th
March 3, 2025
Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial
February 26, 2025
Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' "America Reports"
February 25, 2025
Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer
February 24, 2025
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial
February 18, 2025
Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview
February 13, 2025
Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum
February 10, 2025
Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention
February 3, 2025
Anixa Biosciences CEO Provides Letter to Shareholders
January 20, 2025
Decks in 2025
- Shareholder Meeting (March 2025)
Shareholder meeting · 38 slides · Mar 21, 2025